Your browser doesn't support javascript.
loading
Patient and Family Caregiver Considerations When Selecting Early Breast Cancer Treatment: Implications for Clinical Pathway Development.
Schulman-Green, Dena; Cherlin, Emily; Capasso, Renee; Mougalian, Sarah S; Wang, Shiyi; Gross, Cary P; Bajaj, Preeti S; Eakle, Katherine; Patel, Sharmi; Douglas, Karin; Adelson, Kerin.
Afiliação
  • Schulman-Green D; Yale School of Nursing, PO Box 27399, West Haven, CT, 06516, USA. dena.schulman-green@yale.edu.
  • Cherlin E; Yale School of Public Health, New Haven, CT, USA.
  • Capasso R; Smilow Cancer Hospital, New Haven, CT, USA.
  • Mougalian SS; Smilow Cancer Hospital, New Haven, CT, USA.
  • Wang S; Yale School of Medicine, New Haven, CT, USA.
  • Gross CP; Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale School of Medicine and Yale Cancer Center, New Haven, CT, USA.
  • Bajaj PS; Yale School of Public Health, New Haven, CT, USA.
  • Eakle K; Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale School of Medicine and Yale Cancer Center, New Haven, CT, USA.
  • Patel S; Yale School of Medicine, New Haven, CT, USA.
  • Douglas K; Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale School of Medicine and Yale Cancer Center, New Haven, CT, USA.
  • Adelson K; Genentech, Inc., San Francisco, CA, USA.
Patient ; 13(6): 683-697, 2020 12.
Article em En | MEDLINE | ID: mdl-32508006
A clinical pathway is a tool used by doctors and nurses to help them plan how they will take care of patients. Clinical pathways do not always include what is important to patients and their families. We spoke with patients with breast cancer and their family members. We wanted to learn what is important to them when they are making decisions about how the patient will be treated for cancer. They reported thinking about the kind of cancer the patient had and about pros and cons of different treatment choices. They also thought about how much is known about different treatment choices. Other patients' stories were important. Patients and family members wanted to know how a treatment would affect their bodies, feelings, normal roles in life, and families. They also thought about their relationship with their doctors and nurses and about how they would pay for their care. It was seen as hard to balance these things when making decisions. Patients and family members wanted to make decisions they would be happy with later. We will use this information to create a new clinical pathway. This tool will help patients with breast cancer, family members, doctors, and nurses work together to make the best decisions about the patient's cancer.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Cuidadores Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Cuidadores Idioma: En Ano de publicação: 2020 Tipo de documento: Article